{"SPADE_UN_17031": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_17031", "Peptide Name": "(HHPHG)2", "Source": "Synthetic", "Family": "", "Gene": "Not found", "Sequence": "HHPHGHHPHG", "Sequence Length": 10, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Not available", "Hemolytic Activity": "Not available", "Cytotoxicity": "Not available", "Binding Target": "Not available", "Linear/Cyclic": "", "N-terminal Modification": "Free", "C-terminal Modification": "Acetylation", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C50H64N22O11", "Mass": 1149.18, "PI": 7.21, "Net Charge": 6, "Hydrophobicity": -2.32, "Half Life": "Mammalian:3.5 hourYeast:10 minE.coli:>10 hour", "Literature": [{"Title": "Peptides derived from the histidine-proline domain of the histidine-proline-rich glycoprotein bind to tropomyosin and have antiangiogenic and antitumor activities.", "Pubmed ID": "15313924", "Reference": "Cancer Res. 2004 Aug 15;64(16)5812-7", "Author": "Do√±ate F, Juarez JC, Guan X, Shipulina NV, Plunkett ML, Tel-Tsur Z, Shaw DE, Morgan WT, Mazar AP.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=15313924"}], "Frequent Amino Acids": "HGP", "Absent Amino Acids": "ACDEFIKLMNOQRSTUVWY", "Basic Residues": 6, "Acidic Residues": 0, "Hydrophobic Residues": 2, "Polar Residues": 6, "Positive Residues": 6, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_N_07802", "Similarity": 1.0, "Sequence": "GHHPHGHHPHGHHPHGHHHPH"}, {"SPADE_ID": "SPADE_UN_01618", "Similarity": 1.0, "Sequence": "GHHPHGHHPHGHHPHGHHPH"}, {"SPADE_ID": "SPADE_UN_15300", "Similarity": 1.0, "Sequence": "HHPHGHHPHGHHPHGHHPHG"}]}}}